Skip to main content
Premium Trial:

Request an Annual Quote

MRC, Renishaw Dx Partner on Infectious Disease Tests

NEW YORK (GenomeWeb News) – MRC Technology today announced a collaboration with Renishaw Diagnostics to identify and develop clinical diagnostic tests for infectious diseases.

The collaboration combines Renishaw's multiplex screening technology and expertise in assay development with MRC's experience in developing early-stage research for clinical applications and commercialization, MRC said. The focus will be on identifying and accelerating research with potential in infectious disease diagnostics.

Renishaw's RenDx multiplex assay system is based on surface enhanced resonance Raman scattering, and provides automated, multiplex, in vitro screening for clinical research.

Financial and other terms of the agreement were not disclosed.

"MRC Technology's expertise and experience will allow us to accelerate development of our assay portfolio, enhancing the capabilities of the RenDx platform and providing end users with additional value and flexibility," Renishaw General Manager Rupert Jones said in a statement.

MRC is a London-based technology transfer organization. Renishaw Diagnostics, a subsidiary of the Renishaw Group, is based in Glasgow, Scotland.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.